Filing Details

Accession Number:
0001209191-23-016053
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-03 20:00:36
Reporting Period:
2023-03-01
Accepted Time:
2023-03-03 20:00:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1326969 L Camille Bedrosian C/O Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato CA 94949
Evp And Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-01 2,663 $0.00 50,601 No 4 A Direct
Common Stock Disposition 2023-03-01 3,881 $45.25 46,720 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents shares of common stock into which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.
  2. Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
  3. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.